Bionano Genom (BNGO)
$3.06
0.03 (0.98%)
BNGO Stock Quote Delayed 30 Minutes
Bionano Genomics Moves Into Speculative Buy Territory
Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%. Is it a buy?
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$3.36
Market Cap
9.11M
PE Ratio
-0.05
EPS
-64.7156
Volume (Avg. Vol.)
90,669
Day's Range
$2.99 - $3.24
52-Week Range
$2.68 - $72.60
Dividend & Yield
N/A (N/A)
BNGO Stock Predictions, Articles, and Bionano Genom News
Is Bionano Genomics a Buy Ahead of Earnings?
Don’t mistake Bionano for just any Reddit stock. With its Q1 earnings looming, BNGO stock is attractively priced near its 2021 low.
5 Reddit Penny Stocks Seeing the Most Chatter Tuesday
We're taking another dive into the world of penny stocks on Tuesday with a look at Reddit's most-talked-about for the day.
Don’t Look Now, but Bionano Genomics May Be a Buy
Bionano Genomics has lost a lot of supporters in recent months and some never came to the rescue, but a lifeline has been thrown to BNGO stock.
Don’t Confuse Bionano Genomics As an Investment Right Now
The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now.
Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around
It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity.
Bionano’s UK Deal Is Huge for BNGO Stock
Bionano's deal with the UK leaves the company well-positioned to make deals with many nations. Investors should buy BNGO stock.
Bionano Genomics Stock Is Too Wild for Its Own Good
BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment.
Bionano Genomics Stock Has Huge Potential, But It’s Very Risky
BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.
Bionano Will Eventually Return to Earth Due to Its Weak Fundamentals
Massive dilution, sluggish sales, and ballooning expenses will keep most away from BNGO stock despite its positive attributes.
The Recent Pullback in Bionano Genomics Is a Major Buying Opportunity
BNGO stock has been beaten down as of late, but it presents a great buying opportunity to invest in the emerging life sciences player.
This Is When Bionano Genomics Becomes a Buy
It may have the goods longer term, but a profitable position in BNGO stock in 2021 is tied to the price chart and maybe Ark Invest.
BNGO Stock: 9 Reasons Why Bionano Genomics Shares Are Getting a Boost Today
Bionano Genomics (BNGO) stock is on the rise Wednesday as investors react to news announced by the company after markets closed on Tuesday.
10 Reddit Penny Stocks Seeing the Most Chatter Today
Reddit penny stocks continue to be of interest to risky investors and InvestorPlace is looking at the top ones for Monday.
There’s No Need to Chase Bubbly Bionano Genomics Stock
A single study launched an epic rally in BNGO stock. But the company still has much to prove, and 3,400% gains don't price in the risks.
BioNano Genomics Is About the Future, Not the Present
BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.
Valuation Not Meme Stock Status Should Worry You About Bionano Genomics
Investors in BNGO stock have seen year-over-year stock price appreciation of more than 2,200%, but can it continue long-term?
BioNano Genomics Will Likely Be Volatile Prior to Q4 Earnings
Those investors bullish on genomics might want to analyze the Q4 results of BNGO stock
Even Below the $10 Mark There Are Way Better Buys Than BioNano Genomics
The risk-to-reward proposition has recently gotten a lot better for investors considering BNGO stock. Is it a buy for single digits? Maybe.
BioNano Genomics Is an Excellent Lesson in Technical Analysis
Technically, BNGO stock appeared on the verge of a robust breakout move but with shares tumbling instead, it’s time to reassess the overall picture.
Addressable Market Aside, Bionano Stock Is a Buy on Innovation Alone
Bionano's Saphyr system looks poised to revolutionize diagnostics and medical research, making BNGO stock worth buying for long-term investors.
